CTSL/B-IN-1
CTSLCTSB-IN-1 (compound 212-148) is a bispecific inhibitor of host viral spike cleaver proteins CTSL/CTSB and TMPRSS2 with IC50s of 2.13/64.07 nM and 1.38 μM, respectively. CTSLCTSB-IN-1 blocks two relevant SARS-CoV-2 viral entry pathways by inhibiting the viral spike cleavage and can be applied to anti-SARS-CoV-2 research[1].
Product Specifications
UNSPSC
12352005
Target
Cathepsin; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ctsl-b-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@H](C(N[C@@H](CCC1=CC=CC=C1)/C=C/S(=O)(C2=CC=CC=C2)=O)=O)CC3=CC=CC=C3)N(CC4)CCN4CCOC(C5=CC=C(C=C5)/N=C(N)\N)=O
Molecular Formula
C41H47N7O6S
Molecular Weight
765.92
References & Citations
[1]Haitao Yang, et al. Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry. Nat Commun, .2023, 14, 7574.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Alpha Synuclein (Phospho-Ser129) Rabbit mAb Antibody
Alpha Synuclein (Phospho-Ser129) Rabbit mAb Antibody
Mouse Lymphocytic Choriomeningitis Virus IgG (LCMV-IgG) ELISA Kit
MCHR1 antibody - N-terminal region (ARP63587_P050)
